Table 1 Clinical and pathological characteristics of the whole cohort
Characteristics | Value | |
|---|---|---|
Age (years) | Mean (SD) | 52.2 (10.6) |
Sex | Male | 1575 (85.3%) |
Female | 272 (14.7%) | |
HBV infection | No | 242 (13.1%) |
Yes | 1605 (86.9%) | |
Cirrhosis | No | 610 (33.0%) |
Yes (compensated/decompensated) | 1216 (65.9%)/21 (1.1%) | |
TBil (μmol/L) | Mean (SD) | 14.6 (6.2) |
Child-pugh | A | 1751 (94.8%) |
B | 96 (5.2%) | |
AFP | ≤400 ng/mL | 1255 (67.9%) |
|  | > 400 ng/mL | 592 (32.1%) |
γ-GT | ≤54 U/L | 947 (51.3%) |
|  | > 54 U/L | 900 (48.7%) |
Transfusion | No | 1739 (94.2%) |
| Â | Yes | 108 (5.8%) |
Tumor number | Single | 1499 (81.2%) |
| Â | Multiple | 348 (18.8%) |
Tumor diameter (cm) | Mean (SD) | 5.8 (3.8) |
ES grading | I&II | 172 (9.3%) |
| Â | III&IV | 1675 (90.7%) |
Capsule | Present | 1487 (80.5%) |
| Â | Absent | 360 (19.5%) |
Satellite | No | 1071 (58.0%) |
| Â | Yes | 776 (42.0%) |
MVI | Present | 644 (34.9%) |
| Â | Absent | 1203 (65.1%) |
BCLC | 0 | 107 (5.8%) |
| Â | A | 1446 (78.3%) |
| Â | B | 294 (15.9%) |
AJCC | Ia | 107 (5.8%) |
| Â | Ib | 938 (50.8%) |
| Â | II | 623 (33.7%) |
| Â | IIIa | 179 (9.7%) |
CNLC | Ia | 846 (45.8%) |
| Â | Ib | 707 (38.3%) |
| Â | IIa | 203 (11.0%) |
| Â | IIb | 91 (4.9%) |
PA-TACE | No | 1335 (72.3%) |
| Â | Yes | 512 (27.7%) |